Showing 1 - 10 of 6,707
Persistent link: https://www.econbiz.de/10003092635
Persistent link: https://www.econbiz.de/10011740137
We examine the effect of the Jumpstart Our Business Startups (JOBS) Act on biotech startups, who conduct almost 40% of IPOs since 2012. Reduced compliance costs encourage innovation capital formation as biotech IPO volume increases 200% and proceeds rise by 30%. After the JOBS Act, biotech...
Persistent link: https://www.econbiz.de/10012829465
Persistent link: https://www.econbiz.de/10014319911
We analyse the determinants of network formation in Germany’s biotechnology industry using social network analysis …
Persistent link: https://www.econbiz.de/10009669599
waren, mit denen die dedizierten Biotechnologie-Unternehmen in Deutschland in den Jahren 1999-2009 zu kämpfen hatten. Die … Biotechnologiefirmen in Deutschland, der Nachfolger BioChancePlus erreichte 40% seiner Zielgruppe. Insgesamt erhielten 260 Unternehmen eine …
Persistent link: https://www.econbiz.de/10009561494
of commercial biotechnology in Germany. The current paper tries to fill this gap. We find that although these contests …
Persistent link: https://www.econbiz.de/10003761389
Persistent link: https://www.econbiz.de/10012264993
We analyse the determinants of network formation in German's biotechnology sector combining elements from social network analysis (SNA) and a regression framework for count data. For the latter we adopt a regional innovation system perspective, we estimate the number of total and interregional...
Persistent link: https://www.econbiz.de/10011512962